About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Cardiovascular Diabetology
›
Top Articles
Cardiovascular Diabetology
Endocrinology
8.7
(top 1%)
Impact Factor
9.2
(top 1%)
extended IF
89
(top 4%)
H-Index
2.3K
authors
2.2K
papers
60.6K
citations
3.8K
citing journals
36.5K
citing authors
Most Cited Articles of Cardiovascular Diabetology
Title
Year
Citations
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
2018
580
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice
2005
568
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
2006
477
Association between insulin resistance and the development of cardiovascular disease
2018
472
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
2014
313
How hyperglycemia promotes atherosclerosis: molecular mechanisms
2002
291
Endothelial dysfunction: a comprehensive appraisal
2006
277
Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance
2014
218
On the use of a continuous metabolic syndrome score in pediatric research
2008
213
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
2014
212
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study
2017
189
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
2012
188
Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies
2018
187
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
2005
180
Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes
2017
171
Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
2011
170
Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
2013
164
Diabetes, cardiovascular disease and the microcirculation
2018
162
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
2019
161
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study
2009
155
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
2014
153
The effect of dapagliflozin treatment on epicardial adipose tissue volume
2018
147
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
2005
144
Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties
2011
143
Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
2006
143
previous
2015
2016
2017
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.